HEADER TRANSCRIPTION FACTOR/HORMONE 05-JUN-14 4QK4 TITLE CRYSTAL STRUCTURE OF HUMAN NUCLEAR RECEPTOR SF-1 (NR5A1) BOUND TO PIP2 TITLE 2 AT 2.8 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROIDOGENIC FACTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 218-461; COMPND 5 SYNONYM: SF-1, STF-1, ADRENAL 4-BINDING PROTEIN, FUSHI TARAZU FACTOR COMPND 6 HOMOLOG 1, NUCLEAR RECEPTOR SUBFAMILY 5 GROUP A MEMBER 1, STEROID COMPND 7 HORMONE RECEPTOR AD4BP; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COMPND 12 COACTIVATOR 1-ALPHA; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: UNP RESIDUES 139-152; COMPND 15 SYNONYM: PGC-1-ALPHA, PPAR-GAMMA COACTIVATOR 1-ALPHA, PPARGC-1-ALPHA, COMPND 16 LIGAND EFFECT MODULATOR 6; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AD4BP, FTZF1, NR5A1, RC2003B, SF1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBH4; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 OTHER_DETAILS: PGC-1ALPHA (PEROXISOME PROLIFERATOR-ACTIVATED SOURCE 17 RECEPTOR GAMMA CO-ACTIVATOR-1ALPHA) PEPTIDE CONTAINING RESIDUES 139- SOURCE 18 EEPSLLKKLLLAPA-152 KEYWDS NUCLEAR HORMONE RECEPTOR, NR5A1, SF-1 LIGAND BINDING DOMAIN, KEYWDS 2 REGULATORY LIGANDS, TRANSCRIPTION, TRANSCRIPTION REGULATION, KEYWDS 3 STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 4 PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, PARTNERSHIP FOR STEM CELL KEYWDS 5 BIOLOGY, PIP3, PIP2, NUCLEUS, NUCLEAR PHOSPHATIDYLINOSITOL KEYWDS 6 PHOSPHATES, TRANSCRIPTION FACTOR-HORMONE COMPLEX, STEMCELL EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG),PARTNERSHIP FOR STEM CELL AUTHOR 2 BIOLOGY (STEMCELL) REVDAT 7 13-MAR-24 4QK4 1 COMPND SOURCE REVDAT 6 20-SEP-23 4QK4 1 REMARK REVDAT 5 01-FEB-23 4QK4 1 REMARK SEQADV REVDAT 4 07-MAR-18 4QK4 1 REMARK REVDAT 3 22-NOV-17 4QK4 1 REMARK REVDAT 2 04-FEB-15 4QK4 1 JRNL REVDAT 1 30-JUL-14 4QK4 0 JRNL AUTH R.D.BLIND,E.P.SABLIN,K.M.KUCHENBECKER,H.J.CHIU,A.M.DEACON, JRNL AUTH 2 D.DAS,R.J.FLETTERICK,H.A.INGRAHAM JRNL TITL THE SIGNALING PHOSPHOLIPID PIP3 CREATES A NEW INTERACTION JRNL TITL 2 SURFACE ON THE NUCLEAR RECEPTOR SF-1. JRNL REF PROC.NATL.ACAD.SCI.USA V. 111 15054 2014 JRNL REFN ISSN 0027-8424 JRNL PMID 25288771 JRNL DOI 10.1073/PNAS.1416740111 REMARK 2 REMARK 2 RESOLUTION. 2.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.12 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 10138 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 506 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.7671 - 4.4542 0.99 2524 132 0.1793 0.1969 REMARK 3 2 4.4542 - 3.5387 1.00 2397 126 0.1974 0.2431 REMARK 3 3 3.5387 - 3.0924 1.00 2366 125 0.2353 0.3157 REMARK 3 4 3.0924 - 2.8101 1.00 2345 123 0.2715 0.3931 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 90.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2183 REMARK 3 ANGLE : 0.540 2947 REMARK 3 CHIRALITY : 0.036 344 REMARK 3 PLANARITY : 0.003 366 REMARK 3 DIHEDRAL : 19.460 895 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 218:461) REMARK 3 ORIGIN FOR THE GROUP (A): -19.8699 28.1049 -3.6273 REMARK 3 T TENSOR REMARK 3 T11: 0.5194 T22: 0.4160 REMARK 3 T33: 0.4029 T12: -0.1629 REMARK 3 T13: -0.0340 T23: -0.0857 REMARK 3 L TENSOR REMARK 3 L11: 2.8304 L22: 3.1370 REMARK 3 L33: 2.2074 L12: -1.3020 REMARK 3 L13: 0.2451 L23: -1.2509 REMARK 3 S TENSOR REMARK 3 S11: 0.0652 S12: 0.2173 S13: -0.3101 REMARK 3 S21: 0.0231 S22: -0.0261 S23: 0.2261 REMARK 3 S31: 0.3523 S32: -0.0104 S33: -0.0283 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B AND (RESSEQ 141:152) REMARK 3 ORIGIN FOR THE GROUP (A): -36.0886 18.8358 -8.7622 REMARK 3 T TENSOR REMARK 3 T11: 1.0920 T22: 0.9516 REMARK 3 T33: 1.4315 T12: -0.5508 REMARK 3 T13: -0.2387 T23: -0.1787 REMARK 3 L TENSOR REMARK 3 L11: 5.2050 L22: 3.6018 REMARK 3 L33: 6.9410 L12: 3.1626 REMARK 3 L13: 1.6640 L23: -2.0748 REMARK 3 S TENSOR REMARK 3 S11: 0.0379 S12: 0.5511 S13: -0.5179 REMARK 3 S21: -0.4142 S22: 0.2767 S23: 0.0484 REMARK 3 S31: 0.3473 S32: 0.0987 S33: -0.2808 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 501:501) REMARK 3 ORIGIN FOR THE GROUP (A): -23.7436 44.2590 -11.6308 REMARK 3 T TENSOR REMARK 3 T11: 0.3680 T22: 0.7210 REMARK 3 T33: 0.3239 T12: -0.0094 REMARK 3 T13: -0.0111 T23: 0.1063 REMARK 3 L TENSOR REMARK 3 L11: 5.7634 L22: 6.8955 REMARK 3 L33: 5.9489 L12: 2.7543 REMARK 3 L13: -2.8731 L23: 1.2340 REMARK 3 S TENSOR REMARK 3 S11: -0.1292 S12: 0.9628 S13: 0.9020 REMARK 3 S21: 0.2173 S22: 0.2509 S23: 0.9970 REMARK 3 S31: -0.8343 S32: -1.1967 S33: -0.1139 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. ATOM RECORD CONTAINS SUM OF TLS AND REMARK 3 RESIDUAL B FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND REMARK 3 RESIDUAL U FACTORS. 2. 1,2-ETHANEDIOL (EDO) FROM THE REMARK 3 CRYSTALLIZATION SOLUTION HAS BEEN MODELED IN THE SOLVENT REMARK 3 STRUCTURE. 3. PIP2 WAS CO-CRYSTALLIZED WITH THE SF-1 PROTEIN AND REMARK 3 PGC-1ALPHA PEPTIDE. REMARK 4 REMARK 4 4QK4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000086155. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-SEP-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-002+ REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10167 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.810 REMARK 200 RESOLUTION RANGE LOW (A) : 29.119 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.7200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.81 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.65600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.3.0 REMARK 200 STARTING MODEL: PDB ENTRY 1YOW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SF-1, 6% PEG 8000, 0.2M MGOAC, 20% REMARK 280 ETHYLENE GLYCOL, 0.067MM PIP2, 0.80MM 14-MER EEPSLLKKLLLAPA, REMARK 280 NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.31500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 37.50000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 37.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 34.65750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 37.50000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 37.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 103.97250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 37.50000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.50000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 34.65750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 37.50000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.50000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 103.97250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.31500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLU B 139 REMARK 465 GLU B 140 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 285 -49.00 63.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PIK A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 506 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: JCSG-429246 RELATED DB: TARGETTRACK REMARK 900 RELATED ID: JCSG-429245 RELATED DB: TARGETTRACK REMARK 999 REMARK 999 SEQUENCE REMARK 999 SF-1 (UNIPROT Q13285, NR5A1_HUMAN, STF1_HUMAN) LIGAND BINDING REMARK 999 DOMAIN (LBD) WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY AMINO ACID RESIDUES 218-461 OF THE REMARK 999 TARGET SEQUENCE. RESIDUES C247 AND C412 IN THIS SF-1 CONSTRUCT WERE REMARK 999 MUTATED TO S247 AND S412. PEPTIDE CORRESPONDING TO THE PGC-1ALPHA REMARK 999 (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA CO-ACTIVATOR- REMARK 999 1ALPHA) RESIDUES 139-EEPSLLKKLLLAPA-152 (UNIPROT Q9UBK2, PRGC1_ REMARK 999 HUMAN)WAS CO-CRYSTALLIZED WITH THE SF-1 LBD. DBREF 4QK4 A 218 461 UNP Q13285 STF1_HUMAN 218 461 DBREF 4QK4 B 139 152 UNP Q9UBK2 PRGC1_HUMAN 139 152 SEQADV 4QK4 GLY A 0 UNP Q13285 EXPRESSION TAG SEQADV 4QK4 SER A 247 UNP Q13285 CYS 247 ENGINEERED MUTATION SEQADV 4QK4 SER A 412 UNP Q13285 CYS 412 ENGINEERED MUTATION SEQRES 1 A 245 GLY SER GLY GLY PRO ASN VAL PRO GLU LEU ILE LEU GLN SEQRES 2 A 245 LEU LEU GLN LEU GLU PRO ASP GLU ASP GLN VAL ARG ALA SEQRES 3 A 245 ARG ILE LEU GLY SER LEU GLN GLU PRO THR LYS SER ARG SEQRES 4 A 245 PRO ASP GLN PRO ALA ALA PHE GLY LEU LEU CYS ARG MET SEQRES 5 A 245 ALA ASP GLN THR PHE ILE SER ILE VAL ASP TRP ALA ARG SEQRES 6 A 245 ARG CYS MET VAL PHE LYS GLU LEU GLU VAL ALA ASP GLN SEQRES 7 A 245 MET THR LEU LEU GLN ASN CYS TRP SER GLU LEU LEU VAL SEQRES 8 A 245 PHE ASP HIS ILE TYR ARG GLN VAL GLN HIS GLY LYS GLU SEQRES 9 A 245 GLY SER ILE LEU LEU VAL THR GLY GLN GLU VAL GLU LEU SEQRES 10 A 245 THR THR VAL ALA THR GLN ALA GLY SER LEU LEU HIS SER SEQRES 11 A 245 LEU VAL LEU ARG ALA GLN GLU LEU VAL LEU GLN LEU LEU SEQRES 12 A 245 ALA LEU GLN LEU ASP ARG GLN GLU PHE VAL CYS LEU LYS SEQRES 13 A 245 PHE ILE ILE LEU PHE SER LEU ASP LEU LYS PHE LEU ASN SEQRES 14 A 245 ASN HIS ILE LEU VAL LYS ASP ALA GLN GLU LYS ALA ASN SEQRES 15 A 245 ALA ALA LEU LEU ASP TYR THR LEU CYS HIS TYR PRO HIS SEQRES 16 A 245 SER GLY ASP LYS PHE GLN GLN LEU LEU LEU CYS LEU VAL SEQRES 17 A 245 GLU VAL ARG ALA LEU SER MET GLN ALA LYS GLU TYR LEU SEQRES 18 A 245 TYR HIS LYS HIS LEU GLY ASN GLU MET PRO ARG ASN ASN SEQRES 19 A 245 LEU LEU ILE GLU MET LEU GLN ALA LYS GLN THR SEQRES 1 B 14 GLU GLU PRO SER LEU LEU LYS LYS LEU LEU LEU ALA PRO SEQRES 2 B 14 ALA HET PIK A 501 63 HET EDO A 502 4 HET EDO A 503 4 HET EDO A 504 4 HET EDO A 505 4 HET EDO A 506 4 HETNAM PIK (2S)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6- HETNAM 2 PIK TRIHYDROXY-4,5-BIS(PHOSPHONOOXY) HETNAM 3 PIK CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1,2-DIYL HETNAM 4 PIK DIHEXADECANOATE HETNAM EDO 1,2-ETHANEDIOL HETSYN PIK PI(4,5)P2 DIPALMITOYL (16:0,16:0) HETSYN EDO ETHYLENE GLYCOL FORMUL 3 PIK C41 H81 O19 P3 FORMUL 4 EDO 5(C2 H6 O2) FORMUL 9 HOH *55(H2 O) HELIX 1 1 PRO A 224 LEU A 233 1 10 HELIX 2 2 ASP A 236 GLU A 250 1 15 HELIX 3 3 PRO A 259 ARG A 282 1 24 HELIX 4 4 VAL A 285 LEU A 289 5 5 HELIX 5 5 GLU A 290 HIS A 317 1 28 HELIX 6 6 LEU A 333 ALA A 340 1 8 HELIX 7 7 GLY A 341 LEU A 361 1 21 HELIX 8 8 ASP A 364 PHE A 377 1 14 HELIX 9 9 ASP A 380 LEU A 384 5 5 HELIX 10 10 ASN A 386 TYR A 409 1 24 HELIX 11 11 ASP A 414 GLY A 443 1 30 HELIX 12 12 ASN A 450 GLN A 457 1 8 HELIX 13 13 SER B 142 LEU B 149 1 8 SHEET 1 A 2 SER A 322 LEU A 324 0 SHEET 2 A 2 GLU A 330 GLU A 332 -1 O VAL A 331 N ILE A 323 SITE 1 AC1 16 PHE A 262 LEU A 265 CYS A 266 SER A 303 SITE 2 AC1 16 LEU A 306 VAL A 307 ALA A 340 GLY A 341 SITE 3 AC1 16 LEU A 344 LEU A 347 LEU A 429 TYR A 436 SITE 4 AC1 16 HIS A 439 LYS A 440 HOH A 651 HOH A 652 SITE 1 AC2 3 SER A 275 ASP A 309 ARG A 313 SITE 1 AC3 3 GLN A 314 GLY A 318 GLN A 352 SITE 1 AC4 1 LEU A 456 SITE 1 AC5 2 GLN A 357 CYS A 422 SITE 1 AC6 4 VAL A 424 GLU A 425 ALA A 428 HOH A 647 CRYST1 75.000 75.000 138.630 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013333 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013333 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007213 0.00000